Article Details

Abivax completes induction treatment of last patient in ABX464 phase 2b clinical study in ulcerative ...

Retrieved on: 2021-04-14 16:30:00

Tags for this article:

Click the tags to see associated articles and topics

Abivax completes induction treatment of last patient in ABX464 phase 2b clinical study in ulcerative .... View article details on hiswai:

Excerpt

... a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral ...

Article found on: www.pharmiweb.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up